Mical Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MICAL PHARMS, and when can generic versions of MICAL PHARMS drugs launch?
MICAL PHARMS has one approved drug.
There is one US patent protecting MICAL PHARMS drugs.
There are twenty-two patent family members on MICAL PHARMS drugs in eighteen countries.
Summary for Mical Pharms
| International Patents: | 22 |
| US Patents: | 1 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Mical Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mical Pharms | ULTRAVATE | halobetasol propionate | LOTION;TOPICAL | 208183-001 | Nov 6, 2015 | DISCN | Yes | No | 8,962,028 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
